BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10085438)

  • 1. Clinical outcome in three patients with myelodysplastic syndrome showing polyclonal hematopoiesis.
    Karasawa M; Tsukamoto N; Sakai H; Okamoto K; Maehara T; Naruse T; Morita K; Sato S
    Acta Haematol; 1999 Mar; 101(1):46-9. PubMed ID: 10085438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
    van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
    Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.
    Janssen JW; Buschle M; Layton M; Drexler HG; Lyons J; van den Berghe H; Heimpel H; Kubanek B; Kleihauer E; Mufti GJ
    Blood; 1989 Jan; 73(1):248-54. PubMed ID: 2562924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.
    Tsukamoto N; Morita K; Maehara T; Okamoto K; Karasawa M; Omine M; Naruse T
    Br J Haematol; 1993 Apr; 83(4):589-94. PubMed ID: 8100140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of monoclonal hematopoiesis using restriction fragment length polymorphism (RFLP) of phosphoglycerokinase (PGK) gene in a patient with hypoplastic myelodysplastic syndrome (MDS).
    Miyazaki Y; Kuriyama K; Fujiwara T; Jinnai I; Hirashima K; Tomonaga M
    Intern Med; 1993 Mar; 32(3):255-6. PubMed ID: 8101108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy.
    Ito T; Ohashi H; Kagami Y; Ichikawa A; Saito H; Hotta T
    Leukemia; 1994 May; 8(5):839-43. PubMed ID: 7910221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.
    Ganser A; Janssen JW; Ottmann OG; Seipelt G; Eder M; Becher R; Lindermann A; Herrmann F; Schulz G; Mertelsmann R
    Leukemia; 1991 Jun; 5(6):487-92. PubMed ID: 1676079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission.
    Delforge M; Demuynck H; Verhoef G; Vandenberghe P; Zachée P; Maertens J; Van Duppen V; Boogaerts MA
    Br J Haematol; 1998 Jul; 102(2):486-94. PubMed ID: 9695963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cellular expression of the human MSH2 protein in normal and myelodysplastic haematopoiesis.
    Maeck L; Kohaus P; Haase D; Hiddemann W; Alves F
    Br J Haematol; 2000 Nov; 111(2):650-5. PubMed ID: 11122116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms.
    Tefferi A; Thibodeau SN; Solberg LA
    Blood; 1990 May; 75(9):1770-3. PubMed ID: 1970487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
    Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M
    Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.
    Chang KL; O'Donnell MR; Slovak ML; Dagis AC; Arber DA; Niland JC; Forman SJ
    Leukemia; 2002 Apr; 16(4):623-31. PubMed ID: 11960342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.